Author(s)

M. Nadeem¹, O. Mufti², I. Ahsan³, R. Naheed⁴, S. M. Faheem⁵

¹Muhammad Nadeem MBBS, SUNY, Buffalo, NY, USA.
²Owais Mufti MD, SUNY, Buffalo, NY, USA.
³Irfan Ahsan MD, Abington Memorial Hospital, Abington, PA, USA.
⁴Rabia Naheed MBBS, Fatima Memorial Hospital, Lahore, Pakistan.
⁵Sheikh Muhammad Faheem MBBS, University of IOWA Hospital, Iowa City, IA, USA.

Background: A new method of immune-based therapies has been made and applied on multiple sclerosis patients in last decades. Some of these treatments have a high efficacy and reasonable side effects. In slowing disease progression, present treatments have significant limitations, but often associated with significant adverse effects of immunosuppression, with having a bit low capability to counter the disability. Methods: This is a review meta-analysis of treatment of multiple sclerosis. Results: Thus a valuable aim for multiple sclerosis clinical research is to introduce more effective therapies. Conclusion: It is absolutely necessary to increase the individualized therapy planes development in respect to make better planes to disease-modifying treatments.

Immune Sequestration, Multiple Sclerosis, Non-Specific Immune Modulation, Lymphocyte-Targeted Therapy

Nadeem, M. , Mufti, O. , Ahsan, I. , Naheed, R. and Faheem, S. (2016) Treatment of Multiple Sclerosis. Neuroscience and Medicine, 7, 74-82. doi: 10.4236/nm.2016.72009.